Letter

Prophylactic heparin in palliative care: …to a challenging idea

BMJ 2006; 332 doi: 10.1136/bmj.332.7543.729 (Published 23 March 2006)
Cite this as: BMJ 2006;332:729.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John C Chambers, Macmillan consultant (dr.ch@mbers.info)
  1. Katharine House Hospice, Adderbury, Oxfordshire OX17 3NL

    EDITOR—Twenty eight (100%) hospice inpatients at least five days into thromboprophylaxis with low molecular weight heparin found it acceptable.1 The potential for lengthened life appeared the main reason for wanting prophylaxis and none knew any common symptoms of venous thromboembolism. All had irreversible deteriorations in performance status, and, as cancer itself is a risk for venous thromboembolism, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular